SCHEMBL20446536

SCHEMBL20446536

CO[C@@H]1C[C@H](C(=O)Nc2cc(CC[C@@H](C3CC3)N3CCCCC3=O)ccc2F)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 3/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ F10 P00742 2/20 0.37
▸ LMNA P02545 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MCL1 Q07820 3/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ UCHL1 P09936 1/20 0.32
▸ PARP1 P09874 1/20 0.32
▸ PARP2 Q9UGN5 1/20 0.32
▸ USP30 Q70CQ3 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ P2RX3 P56373 1/20 0.32
▸ CCR3 P51677 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20446602 0.85 CYP1A2 (0.43) KLKB1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL20446617 0.85 CYP1A2 (0.43) KLKB1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL20446506 0.84 CYP1A2 (0.42) KLKB1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL20446448 0.84 CYP1A2 (0.42) KLKB1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL20446521 0.83 KLKB1 (0.52) KLKB1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL20446528 0.83 KLKB1 (0.52) KLKB1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL20446526 0.83 KLKB1 (0.52) KLKB1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL3828777 0.78 F10 (0.48) CYP1A2POLBCYP3A4CYP2C19F10
SCHEMBL29582315 0.77 KLKB1 (0.55) KLKB1F10GAA
SCHEMBL28721772 0.77 KLKB1 (0.55) KLKB1F10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3355890-A1 HUMAN PLASMA KALLIKREIN INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2018-08-08 — — EP disclosed
Send feedback